Dr. Yu Yu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award
Curtin University Medical School | Australia
Author Profile
Early Academic Pursuits 🎓
Dr. Yu Yu embarked on her academic journey at the University of Sydney, where she earned her Bachelor of Medical Science in 2005. She further distinguished herself by completing an Honours in Medical Science with First Class in 2006. Her dedication to research culminated in a Doctorate of Philosophy in 2011, marking the beginning of a promising career in medical science and research.
Professional Endeavors 🏢
Currently, Dr. Yu Yu serves as the Program Lead at the Curtin Medical School and the Curtin Health Innovation Research Institute (CHIRI) in Australia. Her professional journey includes significant roles such as Senior Research Fellow at Curtin University since 2017 and Adjunct Senior Lecturer at the University of Western Australia Medical School since 2019. Her past appointments include Research Fellow at Johns Hopkins School of Medicine and Postdoctoral Fellow at the University of Sydney, reflecting a robust background in gynecologic pathology and molecular pharmacology.
Contributions and Research Focus 🔬
Dr. Yu Yu's research contributions are vast and impactful. She has led numerous projects funded by prestigious grants, including the Innovation Seed Fund and the Endometriosis Research Award. Her research primarily focuses on oncology therapeutics, gynecology, and the molecular mechanisms underlying cancer, particularly ovarian cancer. Her notable publications in high-impact journals highlight her expertise in cancer mutations, stem cell biology, and regenerative medicine.
Accolades and Recognition 🏆
Dr. Yu Yu's excellence in research has been recognized through multiple awards and fellowships. She received the Raine Priming Grant, where she was honored as the top-ranked candidate. Additionally, she has been a recipient of the WA Near-Miss Awards for Emerging Leaders and several other grants from the Department of Health Western Australia. Her accolades underscore her significant contributions to medical research and her role as a leader in her field.
Impact and Influence 🌟
Dr. Yu Yu has made a profound impact on the scientific community through her mentoring and teaching roles. She currently supervises multiple PhD and Honours students, fostering the next generation of researchers. Her lectures on cancer mutations and stem cell biology at Curtin University inspire and educate future medical professionals. Moreover, her leadership roles in diversity, inclusion, and belonging initiatives highlight her commitment to creating an inclusive and supportive academic environment.
Legacy and Future Contributions 🔮
Dr. Yu Yu's legacy is defined by her dedication to advancing medical research and her influence as a mentor and educator. Her ongoing research and leadership at Curtin Health Innovation Research Institute ensure that her contributions will continue to shape the field of medical science. Her work in cancer therapeutics and gynecology holds promise for future breakthroughs, and her commitment to diversity and inclusion will leave a lasting impact on the academic community.
Publications 📚
📜B cell epitope mapping: The journey to better vaccines and therapeutic antibodies
- Authors: Asha Joanne De Leon , M. Christian Tjiam , Yu Yu
- Journal: Biochimica et Biophysica Acta (BBA) - General Subjects
- Year: 2024
📜Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones
- Authors: Denisenko, E. , de Kock, L. , Tan, A. , Yu, Y. , Forrest, A.R.R.
- Journal: Nature Communications
- Year: 2024
📜Multi-compartment tumor organoids
- Authors: Lee, M.-H. , Russo, G.C. , Rahmanto, Y.S. , Wang, T.-L. , Wirtz, D.
- Journal: Materials Today
- Year: 2022
📜Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?
- Authors: Rendell, A. , Thomas-Bland, I. , McCuish, L. , Binju, M. , Yu, Y.
- Journal: Biomedicines
- Year: 2022
📜MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
- Authors: Kang, E.Y. , Millstein, J. , Popovic, G. , Kelemen, L.E. , Köbel, M.
- Journal: Virchows Archiv
- Year: 2022